CDLX
Cardlytics, Inc.
CDLX trails on the overall score without a compensating advantage in the available component scores.
META
Meta Platforms, Inc.
META has the edge over CDLX overall, supported by lower modeled downside and stronger valuation.
CDLX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CDLX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CDLX PE Valuation
CDLX has no meaningful PE right now: it lost money over the past year.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
CDLX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CDLX's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
CDLX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$6.42 | +$15.18 |
| Q2 2026 | -$18.50 | +$18.50 |
| Q1 2026 | -$17.72 | +$18.38 |
| Q4 2025 | -$19.50 | +$19.60 |
| Q3 2025 | -$21.60 | +$40.45 |
| Q2 2025 | -$37.00 | +$2.35 |
| Q1 2025 | -$36.10 | +$9.05 |
| Q4 2024 | -$39.10 | -$3.55 |
CDLX is still losing money, but far less than before: $6.42 per share over the past year, against $145.30 at its worst in early 2023.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over CDLX on earnings quality, reporting a profit while its opponent remains loss making.
CDLX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | -37% |
| Q2 2026 | $36.9M | -42% |
| Q1 2026 | $34.3M | -45% |
| Q4 2025 | $56.1M | -24% |
| Q3 2025 | $52M | -22% |
| Q2 2025 | $63.2M | -9.2% |
| Q1 2025 | $61.9M | -8.4% |
| Q4 2024 | $74M | -17% |
CDLX's revenue has slid since its 2021 peak: $33M last quarter, down 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | +116 points |
| Q2 2026 | -15% | +5.5 points |
| Q1 2026 | -24% | -1.4 points |
| Q4 2025 | -11% | +0.4 points |
| Q3 2025 | -132% | +89 points |
| Q2 2025 | -20% | +2.5 points |
| Q1 2025 | -23% | +11 points |
| Q4 2024 | -11% | +104 points |
CDLX's operating margin was −16% last quarter, up 116 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over CDLX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over CDLX on profitability, with a higher operating margin.
CDLX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.9M | -439% |
| Q2 2026 | -$8.6M | -1052% |
| Q1 2026 | -$5.7M | +$1.2M |
| Q4 2025 | $13M | +355% |
| Q3 2025 | $1.7M | +99% |
| Q2 2025 | $903K | -78% |
| Q1 2025 | -$6.8M | +$11.4M |
| Q4 2024 | $2.9M | +7.4% |
CDLX's free cash flow was −$7M over the past year, against −$1M the year before.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over CDLX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CDLX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +143K shares |
| 1 year | +10% | +553K shares |
| 3 years | +55% | +2.1M shares |
| 5 years | +116% | +3.2M shares |
| Available history | +149% | +3.5M shares |
CDLX has 6M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q4 2024 | $309,000 |
| Q3 2024 | $119,000 |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over CDLX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
CDLX Net Leverage
CDLX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
CDLX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.0 | Oversold |
| Stochastic | 5.9 | Oversold |
CDLX's weekly RSI is 28 (oversold) and its Stochastic is 6 (oversold).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
CDLX PE vs Communication Services Sector
CDLX has no meaningful PE right now: it lost money over the past year.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
CDLX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.11 | 32% below |
| 20 week MA | $3.25 | 56% below |
| 50 week MA | $6.64 | 78% below |
| 100 week MA | $13.8 | 90% below |
| 200 week MA | $46.7 | 97% below |
CDLX is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has the edge over CDLX on trend strength, trading above more of its moving averages.
CDLX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $649.6 | $1,430.2 | +120% |
| 2021 | $1,430.2 | $662.5 | -54% |
| 2022 | $662.5 | $48.2 | -93% |
| 2023 | $48.2 | $92.1 | +91% |
| 2024 | $92.1 | $37.3 | -60% |
| 2025 | $37.3 | $11.9 | -68% |
| 2026 YTD | $11.9 | $1.43 | -88% |
CDLX's yearly returns have swung widely, from +120% in 2020 to −93% in 2022. It's down 88% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over CDLX on returns for 2026, with the stronger performance.